Literature DB >> 1372450

New perspectives in lung cancer. 4. Haematopoietic growth factors and lung cancer treatment.

N Thatcher1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1372450      PMCID： PMC463590          DOI： 10.1136/thx.47.2.119

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  37 in total

1.  Blood-derived haematopoietic cell transplants: blood to blood?

Authors:  P R Henon; A Butturini; R P Gale
Journal:  Lancet       Date:  1991-04-20       Impact factor: 79.321

Review 2.  Hemopoietins in oncology: factoring out myelosuppression.

Authors:  J D Griffin
Journal:  J Clin Oncol       Date:  1989-02       Impact factor: 44.544

3.  Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines.

Authors:  B R Avalos; J C Gasson; C Hedvat; S G Quan; G C Baldwin; R H Weisbart; R E Williams; D W Golde; J F DiPersio
Journal:  Blood       Date:  1990-02-15       Impact factor: 22.113

4.  WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.

Authors:  D Glover; J H Glick; C Weiler; K Fox; D Guerry
Journal:  J Clin Oncol       Date:  1987-04       Impact factor: 44.544

5.  Frequent expression of receptors for granulocyte-macrophage colony-stimulating factor on human nonhematopoietic tumor cell lines.

Authors:  K Miyagawa; S Chiba; K Shibuya; Y F Piao; S Matsuki; J Yokota; M Terada; K Miyazono; F Takaku
Journal:  J Cell Physiol       Date:  1990-06       Impact factor: 6.384

Review 6.  Biology and clinical use of GM-CSF in lung cancer.

Authors:  P Drings; J R Fischer
Journal:  Lung       Date:  1990       Impact factor: 2.584

7.  The effects of five hematopoietic growth factors on human small cell lung carcinoma cell lines: interleukin 3 enhances the proliferation in one of the eleven cell lines.

Authors:  E Vellenga; B Biesma; C Meyer; L Wagteveld; M Esselink; E G de Vries
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

8.  Decreased erythropoietin response in patients with the anemia of cancer.

Authors:  C B Miller; R J Jones; S Piantadosi; M D Abeloff; J L Spivak
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

9.  Recombinant human GM-CSF in small cell lung cancer: a phase I/II study.

Authors:  H Anderson; H Gurney; N Thatcher; R Swindell; J H Scarffe; J Weiner
Journal:  Recent Results Cancer Res       Date:  1991

10.  Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF.

Authors:  F Ravagnani; S Siena; M Bregni; G Sciorelli; A M Gianni; G Pellegris
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162
View more
  1 in total

1.  A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.

Authors:  J P Sculier; M Paesmans; J Lecomte; O Van Cutsem; J J Lafitte; T Berghmans; G Koumakis; M C Florin; J Thiriaux; J Michel; V Giner; M C Berchier; P Mommen; V Ninane; J Klastersky
Journal:  Br J Cancer       Date:  2001-11-16       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.